Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in Policy / Pricing

EU invests 30m to fight antimicrobial resistance

 April 8, 2026

Pharmaphorum

The EU has pledged 30m in funding for countermeasures to antimicrobial resistance, earmarked for the discovery and development of new antibacterials.

Policy / PricingInfectious DiseaseRead full story

Post navigation

RoosterBio and MineBio team up to expand MSC solutions access in China →
← List Price Reductions Will Deflate the Gross-to-Net Bubble-and Threaten Pharmacy and 340B Profits from IRA-Negotiated Drugs (rerun)

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com